Vir Biotechnology (VIR) Other Operating Expenses (2019 - 2025)

Vir Biotechnology (VIR) has 6 years of Other Operating Expenses data on file, last reported at $26000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses fell 96.2% year-over-year to $26000.0; the trailing twelve-month figure through Mar 2026 stood at $26000.0 (down 96.69% YoY), and the FY2025 full-year result was $26000.0, down 96.92% from the prior year.
• Other Operating Expenses advanced to $26000.0 in Q4 2025, from -$11000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $90.1 million in Q1 2022 to a low of -$11000.0 in Q3 2025.
• A 5-year average of $12.0 million and a median of $741000.0 in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses soared 2340.65% in 2022 and slumped 122.0% in 2025, its largest moves.
• Tracing VIR's Other Operating Expenses over 5 years: stood at $56.9 million in 2021, then slumped by 89.46% to $6.0 million in 2022, then tumbled by 86.69% to $798000.0 in 2023, then declined by 14.29% to $684000.0 in 2024, then slumped by 96.2% to $26000.0 in 2025.
• Business Quant data shows VIR's Other Operating Expenses at $26000.0 in Q4 2025, -$11000.0 in Q3 2025, and $11000.0 in Q2 2025.